APP and Alzheimer disease: While in human neuroblastoma cells (SHSY5YAPP+), CBD demonstrated neuroprotective properties by promoting ubiquitination of the amyloid precursor protein (APP), which is an indicator of cellular changes in the brain of patients with Alzheimer’s disease (Scuderi et al., 2014).